Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
Current price | $32.60 | 52-week high | $170.47 |
Prev. close | $33.61 | 52-week low | $31.94 |
Day low | $32.46 | Volume | 9,646,700 |
Day high | $33.77 | Avg. volume | 12,655,056 |
50-day MA | $40.27 | Dividend yield | N/A |
200-day MA | $81.03 | Market Cap | 12.55B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Price Returns
1-mo | N/A |
3-mo | -30.39% |
6-mo | -59.90% |
1-year | -62.70% |
3-year | -80.13% |
5-year | 37.84% |
YTD | -21.60% |
2024 | -58.19% |
2023 | -44.63% |
2022 | -29.28% |
2021 | 143.11% |
2020 | 434.10% |
Loading social stream, please wait...